{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Alligator Bioscience", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:50:52Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB reports financial results for the period 1 January - 31 March 2026 and provides a business update", "category": "Interim report (Q1 and Q3)", "date": "2026-05-05", "language": "en", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd1471d46077f5b7838b400ec9bdddbb8&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "2026 Q1 EN VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/afbb9d8d7be332ccffec0525d92709386", "final_url": "https://attachment.news.eu.nasdaq.com/afbb9d8d7be332ccffec0525d92709386", "filename": "2026_Q1_EN_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\2026_Q1_EN_VF.pdf", "content_type": "application/pdf", "size": 1205048, "sha256": "c173b55c9b92ad0f5bf034ffc6a3d85100a5273744339b8bcd328bd6850fb28d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\2026_Q1_EN_VF.pdf", "filename": "2026_Q1_EN_VF.pdf", "extension": ".pdf", "size": 1205048, "sha256": "c173b55c9b92ad0f5bf034ffc6a3d85100a5273744339b8bcd328bd6850fb28d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\extracted\\2026_Q1_EN_VF\\2026_Q1_EN_VF.txt", "text_chars": 72994, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2026-q1\\extracted\\2026_Q1_EN_VF\\2026_Q1_EN_VF.extraction.json" } } ], "announcement_id": "1439537", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:00Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience publicerar årsredovisning för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-26", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9bd11e3e670ec21cc8b03a3ab6d3cbb5&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "AR 2025 SV VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad641651bcd9bc5c20804648bc0d2e9a0", "final_url": "https://attachment.news.eu.nasdaq.com/ad641651bcd9bc5c20804648bc0d2e9a0", "filename": "AR_2025_SV_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\AR_2025_SV_VF.pdf", "content_type": "application/pdf", "size": 7131114, "sha256": "91f91f7ceb320969331497cb41f02223304c190217337f3abcfc4ec60a05a8ed", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\AR_2025_SV_VF.pdf", "filename": "AR_2025_SV_VF.pdf", "extension": ".pdf", "size": 7131114, "sha256": "91f91f7ceb320969331497cb41f02223304c190217337f3abcfc4ec60a05a8ed", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\extracted\\AR_2025_SV_VF\\AR_2025_SV_VF.txt", "text_chars": 345423, "metadata": { "page_count": 114, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\extracted\\AR_2025_SV_VF\\AR_2025_SV_VF.extraction.json" } }, { "label": "Ersattningsrapport 2025 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/afd0c7e7853223a8070b03e76f04066a5", "final_url": "https://attachment.news.eu.nasdaq.com/afd0c7e7853223a8070b03e76f04066a5", "filename": "Ersattningsrapport_2025_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\Ersattningsrapport_2025_VF.pdf", "content_type": "application/pdf", "size": 1292136, "sha256": "fa0f24eced5c77d0bae2c2919116e0b37fea7abec645252fb69642919443b4e2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\Ersattningsrapport_2025_VF.pdf", "filename": "Ersattningsrapport_2025_VF.pdf", "extension": ".pdf", "size": 1292136, "sha256": "fa0f24eced5c77d0bae2c2919116e0b37fea7abec645252fb69642919443b4e2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\extracted\\Ersattningsrapport_2025_VF\\Ersattningsrapport_2025_VF.txt", "text_chars": 9523, "metadata": { "page_count": 5, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-annual\\extracted\\Ersattningsrapport_2025_VF\\Ersattningsrapport_2025_VF.extraction.json" } } ], "announcement_id": "1429250", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:07Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2025 och ger en affärsuppdatering", "category": "Bokslutskommuniké", "date": "2026-02-12", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7a5e5f5bc6e8085c3db6f16b3f258757&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "2025 Q4 SE VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a79224ea811094732bc66868aaec083b3", "final_url": "https://attachment.news.eu.nasdaq.com/a79224ea811094732bc66868aaec083b3", "filename": "2025_Q4_SE_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\2025_Q4_SE_VF.pdf", "content_type": "application/pdf", "size": 1215745, "sha256": "9c94521745c3e6d8e6f6738c57a822ab08268220dedbb0d3d8f8f9dd379c55a8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\2025_Q4_SE_VF.pdf", "filename": "2025_Q4_SE_VF.pdf", "extension": ".pdf", "size": 1215745, "sha256": "9c94521745c3e6d8e6f6738c57a822ab08268220dedbb0d3d8f8f9dd379c55a8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\extracted\\2025_Q4_SE_VF\\2025_Q4_SE_VF.txt", "text_chars": 86169, "metadata": { "page_count": 32, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q4\\extracted\\2025_Q4_SE_VF\\2025_Q4_SE_VF.extraction.json" } } ], "announcement_id": "1419703", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:12Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB reports financial results for Q3 2025 and provides a business update", "category": "Interim report (Q1 and Q3)", "date": "2025-10-23", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd1e869f804f050dcac5f545f86c5a5ba&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "2025 Q3 EN.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad325535825e91a50cc23d9f41b696fbb", "final_url": "https://attachment.news.eu.nasdaq.com/ad325535825e91a50cc23d9f41b696fbb", "filename": "2025_Q3_EN.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\2025_Q3_EN.pdf", "content_type": "application/pdf", "size": 1250796, "sha256": "f00fa60821773923862360e1a450dc872f198d3e6ebca104fe0ab2c0538bc9f2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\2025_Q3_EN.pdf", "filename": "2025_Q3_EN.pdf", "extension": ".pdf", "size": 1250796, "sha256": "f00fa60821773923862360e1a450dc872f198d3e6ebca104fe0ab2c0538bc9f2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\extracted\\2025_Q3_EN\\2025_Q3_EN.txt", "text_chars": 81271, "metadata": { "page_count": 30, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q3\\extracted\\2025_Q3_EN\\2025_Q3_EN.extraction.json" } } ], "announcement_id": "1396133", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:16Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för det andra kvartalet 2025 och ger en affärsuppdatering", "category": "Halvårsrapport", "date": "2025-07-10", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4c3af77b9afa83ffe9bc7b1e1b835d0e&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "2025 Q2 SE V1 0.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac495709d3fe84446d2f04dcec1586d62", "final_url": "https://attachment.news.eu.nasdaq.com/ac495709d3fe84446d2f04dcec1586d62", "filename": "2025_Q2_SE_V1_0.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\2025_Q2_SE_V1_0.pdf", "content_type": "application/pdf", "size": 1231411, "sha256": "216095aef7d87c9b99d9458b8069c8bc2f010ca514ec5a9f6eef2b84e1c14a28", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\2025_Q2_SE_V1_0.pdf", "filename": "2025_Q2_SE_V1_0.pdf", "extension": ".pdf", "size": 1231411, "sha256": "216095aef7d87c9b99d9458b8069c8bc2f010ca514ec5a9f6eef2b84e1c14a28", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\extracted\\2025_Q2_SE_V1_0\\2025_Q2_SE_V1_0.txt", "text_chars": 76107, "metadata": { "page_count": 29, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q2\\extracted\\2025_Q2_SE_V1_0\\2025_Q2_SE_V1_0.extraction.json" } } ], "announcement_id": "1377235", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:22Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB reports financial results for Q1 2025 and provides a business update", "category": "Interim report (Q1 and Q3)", "date": "2025-04-24", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b14bba0d65d18dea977f21552e9265738&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "2025 Q1 EN VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5cdbfaa7c79ad9e62fde2758ea8d6f1a", "final_url": "https://attachment.news.eu.nasdaq.com/a5cdbfaa7c79ad9e62fde2758ea8d6f1a", "filename": "2025_Q1_EN_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\2025_Q1_EN_VF.pdf", "content_type": "application/pdf", "size": 1216759, "sha256": "fb12b3215d4cf16ff7b5ecc26ac016af02c4317b428849b60d4f9a64df7a8b9d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\2025_Q1_EN_VF.pdf", "filename": "2025_Q1_EN_VF.pdf", "extension": ".pdf", "size": 1216759, "sha256": "fb12b3215d4cf16ff7b5ecc26ac016af02c4317b428849b60d4f9a64df7a8b9d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\extracted\\2025_Q1_EN_VF\\2025_Q1_EN_VF.txt", "text_chars": 72834, "metadata": { "page_count": 29, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2025-q1\\extracted\\2025_Q1_EN_VF\\2025_Q1_EN_VF.extraction.json" } } ], "announcement_id": "1357674", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:36Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience publicerar årsredovisning för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-03-27", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf9a7bc0ba90da9324b65403cd49e6e2c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "Alligator Ersattningsrapport 2024 SV VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a732b6171fa4f3385753053741f37eb0d", "final_url": "https://attachment.news.eu.nasdaq.com/a732b6171fa4f3385753053741f37eb0d", "filename": "Alligator_Ersattningsrapport_2024_SV_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\Alligator_Ersattningsrapport_2024_SV_VF.pdf", "content_type": "application/pdf", "size": 579117, "sha256": "7d6de47db7f7a545b897c69b5e84a30bb29abdc7a274947b6d06391144d2fa0a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\Alligator_Ersattningsrapport_2024_SV_VF.pdf", "filename": "Alligator_Ersattningsrapport_2024_SV_VF.pdf", "extension": ".pdf", "size": 579117, "sha256": "7d6de47db7f7a545b897c69b5e84a30bb29abdc7a274947b6d06391144d2fa0a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\extracted\\Alligator_Ersattningsrapport_2024_SV_VF\\Alligator_Ersattningsrapport_2024_SV_VF.txt", "text_chars": 14613, "metadata": { "page_count": 5, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\extracted\\Alligator_Ersattningsrapport_2024_SV_VF\\Alligator_Ersattningsrapport_2024_SV_VF.extraction.json" } }, { "label": "Alligator Annual Report 2024 SE VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac2da60a0a0edcae413b97efdc3451f44", "final_url": "https://attachment.news.eu.nasdaq.com/ac2da60a0a0edcae413b97efdc3451f44", "filename": "Alligator_Annual_Report_2024_SE_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\Alligator_Annual_Report_2024_SE_VF.pdf", "content_type": "application/pdf", "size": 6528466, "sha256": "070896377b3e7557b350de90c8d3d93dc4be0f2a60704fb7b3a3fb560d902757", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\Alligator_Annual_Report_2024_SE_VF.pdf", "filename": "Alligator_Annual_Report_2024_SE_VF.pdf", "extension": ".pdf", "size": 6528466, "sha256": "070896377b3e7557b350de90c8d3d93dc4be0f2a60704fb7b3a3fb560d902757", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\extracted\\Alligator_Annual_Report_2024_SE_VF\\Alligator_Annual_Report_2024_SE_VF.txt", "text_chars": 293277, "metadata": { "page_count": 88, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-annual\\extracted\\Alligator_Annual_Report_2024_SE_VF\\Alligator_Annual_Report_2024_SE_VF.extraction.json" } } ], "announcement_id": "1351885", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:39Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2024 och ger en affärsuppdatering", "category": "Bokslutskommuniké", "date": "2025-01-22", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2f3ef5a4cef4f8df1f2e21f2a2366dc1&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "2024Q4 SE 22 Jan 2025 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7d940865ecfd823495e7172af5e02f93", "final_url": "https://attachment.news.eu.nasdaq.com/a7d940865ecfd823495e7172af5e02f93", "filename": "2024Q4_SE_22_Jan_2025_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\2024Q4_SE_22_Jan_2025_VF.pdf", "content_type": "application/pdf", "size": 2718298, "sha256": "b169634a23686a5edd24adfe9340090e451f284f380fceff260c39d4486dbf34", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\2024Q4_SE_22_Jan_2025_VF.pdf", "filename": "2024Q4_SE_22_Jan_2025_VF.pdf", "extension": ".pdf", "size": 2718298, "sha256": "b169634a23686a5edd24adfe9340090e451f284f380fceff260c39d4486dbf34", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\extracted\\2024Q4_SE_22_Jan_2025_VF\\2024Q4_SE_22_Jan_2025_VF.txt", "text_chars": 79267, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q4\\extracted\\2024Q4_SE_22_Jan_2025_VF\\2024Q4_SE_22_Jan_2025_VF.extraction.json" } } ], "announcement_id": "1338341", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:45Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för de första nio månaderna och Q3 2024, samt ger en affärsuppdatering", "category": "Interimsrapport", "date": "2024-10-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1a1f46c2d33278338de6b90c923a6139&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "2024Q3 SE Oct 2024 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac61f8f772e309a8f16a981a9a9fa8526", "final_url": "https://attachment.news.eu.nasdaq.com/ac61f8f772e309a8f16a981a9a9fa8526", "filename": "2024Q3_SE_Oct_2024_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\2024Q3_SE_Oct_2024_VF.pdf", "content_type": "application/pdf", "size": 3084201, "sha256": "755ae192c82e79fc222bbafcaa3fd14e0164b1905abf0c268f753509fad4509c", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\2024Q3_SE_Oct_2024_VF.pdf", "filename": "2024Q3_SE_Oct_2024_VF.pdf", "extension": ".pdf", "size": 3084201, "sha256": "755ae192c82e79fc222bbafcaa3fd14e0164b1905abf0c268f753509fad4509c", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\extracted\\2024Q3_SE_Oct_2024_VF\\2024Q3_SE_Oct_2024_VF.txt", "text_chars": 78173, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q3\\extracted\\2024Q3_SE_Oct_2024_VF\\2024Q3_SE_Oct_2024_VF.extraction.json" } } ], "announcement_id": "1323170", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:52Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat i delårsrapport för H1 2024 och Q2 2024 och ger en affärsuppdatering", "category": "Halvårsrapport", "date": "2024-07-11", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=baf4a2fa047a50e7f5e0d0164aa925e6b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "2024Q2 SE Jul 2024 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7a64c862daa42128331c5f84bf3a9042", "final_url": "https://attachment.news.eu.nasdaq.com/a7a64c862daa42128331c5f84bf3a9042", "filename": "2024Q2_SE_Jul_2024_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\2024Q2_SE_Jul_2024_VF.pdf", "content_type": "application/pdf", "size": 3090492, "sha256": "9524a48d0f6d3b1d86a73d6ad340c18e16062940bd7f90440e920dae6b6a4968", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\2024Q2_SE_Jul_2024_VF.pdf", "filename": "2024Q2_SE_Jul_2024_VF.pdf", "extension": ".pdf", "size": 3090492, "sha256": "9524a48d0f6d3b1d86a73d6ad340c18e16062940bd7f90440e920dae6b6a4968", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\extracted\\2024Q2_SE_Jul_2024_VF\\2024Q2_SE_Jul_2024_VF.txt", "text_chars": 84937, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q2\\extracted\\2024Q2_SE_Jul_2024_VF\\2024Q2_SE_Jul_2024_VF.extraction.json" } } ], "announcement_id": "1305938", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:51:55Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience offentliggör finansiering om upp till 80 MSEK som förlänger kassalikviditet till Q1 2025", "category": "Insiderinformation", "date": "2024-06-25", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb1f84f57234d7da35f9fc34f087dc3ba&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "Alligator Bioscience offentliggor finansiering om upp till 80 MSEK som forlanger kassalikviditet till Q1 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0418f29b7964250d1218fd7ca0bec65a", "final_url": "https://attachment.news.eu.nasdaq.com/a0418f29b7964250d1218fd7ca0bec65a", "filename": "Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf", "content_type": "application/pdf", "size": 83038, "sha256": "c299967224e7a88dba9dd77f3eac8d21e53a4d57e59e07c92ef7ab6415bd63c8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf", "filename": "Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf", "extension": ".pdf", "size": 83038, "sha256": "c299967224e7a88dba9dd77f3eac8d21e53a4d57e59e07c92ef7ab6415bd63c8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\extracted\\Alligator_Bioscience_offentliggor_finansierin\\Alligator_Bioscience_offentliggor_finansiering_om_.txt", "text_chars": 17268, "metadata": { "page_count": 7, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2024-q1\\extracted\\Alligator_Bioscience_offentliggor_finansierin\\Alligator_Bioscience_offentliggor_finansiering_om_.extraction.json" } } ], "announcement_id": "1303384", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:52:08Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience publicerar årsredovisning för 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-03-21", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b0a6b05c3a44a0ee36dc44a40090e12da&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "Arsredovisning 2023 SE VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a54e1a37bc80719993d2e8beed9beae4c", "final_url": "https://attachment.news.eu.nasdaq.com/a54e1a37bc80719993d2e8beed9beae4c", "filename": "Arsredovisning_2023_SE_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\Arsredovisning_2023_SE_VF.pdf", "content_type": "application/pdf", "size": 15333373, "sha256": "c766b06f29432d33d063e3e709ba5af42c077b3a05b0271711d31a020f0c93d1", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\Arsredovisning_2023_SE_VF.pdf", "filename": "Arsredovisning_2023_SE_VF.pdf", "extension": ".pdf", "size": 15333373, "sha256": "c766b06f29432d33d063e3e709ba5af42c077b3a05b0271711d31a020f0c93d1", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\extracted\\Arsredovisning_2023_SE_VF\\Arsredovisning_2023_SE_VF.txt", "text_chars": 339343, "metadata": { "page_count": 102, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\extracted\\Arsredovisning_2023_SE_VF\\Arsredovisning_2023_SE_VF.extraction.json" } }, { "label": "Ersattningsrapport 2023.pdf", "url": "https://attachment.news.eu.nasdaq.com/a62e7f3c70cecceed86bb14b738420a7f", "final_url": "https://attachment.news.eu.nasdaq.com/a62e7f3c70cecceed86bb14b738420a7f", "filename": "Ersattningsrapport_2023.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\Ersattningsrapport_2023.pdf", "content_type": "application/pdf", "size": 2276909, "sha256": "a0bae4c64b97e5935fbc81dc70fde09715b14039c35b553c6e2910f62235d96e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\Ersattningsrapport_2023.pdf", "filename": "Ersattningsrapport_2023.pdf", "extension": ".pdf", "size": 2276909, "sha256": "a0bae4c64b97e5935fbc81dc70fde09715b14039c35b553c6e2910f62235d96e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\extracted\\Ersattningsrapport_2023\\Ersattningsrapport_2023.txt", "text_chars": 13733, "metadata": { "page_count": 4, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-annual\\extracted\\Ersattningsrapport_2023\\Ersattningsrapport_2023.extraction.json" } } ], "announcement_id": "1282829", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:52:14Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2023 och ger en affärsuppdatering", "category": "Bokslutskommuniké", "date": "2024-02-08", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9f7a570a12566cd199becfa8484c5264&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "2023Q4 SE Feb 2024 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a411c4a9955c484db62fdbab71c8c1d17", "final_url": "https://attachment.news.eu.nasdaq.com/a411c4a9955c484db62fdbab71c8c1d17", "filename": "2023Q4_SE_Feb_2024_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\2023Q4_SE_Feb_2024_VF.pdf", "content_type": "application/pdf", "size": 1766601, "sha256": "54d93871fa5928040ca2179275bceefe1a82ed2dfd0d467dcbd0fc2b88ca0b6e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\2023Q4_SE_Feb_2024_VF.pdf", "filename": "2023Q4_SE_Feb_2024_VF.pdf", "extension": ".pdf", "size": 1766601, "sha256": "54d93871fa5928040ca2179275bceefe1a82ed2dfd0d467dcbd0fc2b88ca0b6e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\extracted\\2023Q4_SE_Feb_2024_VF\\2023Q4_SE_Feb_2024_VF.txt", "text_chars": 82098, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q4\\extracted\\2023Q4_SE_Feb_2024_VF\\2023Q4_SE_Feb_2024_VF.extraction.json" } } ], "announcement_id": "1273725", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:52:20Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat för de första nio månaderna och Q3 2023 och ger en affärsuppdatering", "category": "Interimsrapport", "date": "2023-10-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2aeab80dc53e99c2810bab8c43d15dd0&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "2023Q3 SE 26 Oct 2023 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa9c670249a94a7369ab5b56dbe1eef38", "final_url": "https://attachment.news.eu.nasdaq.com/aa9c670249a94a7369ab5b56dbe1eef38", "filename": "2023Q3_SE_26_Oct_2023_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\2023Q3_SE_26_Oct_2023_VF.pdf", "content_type": "application/pdf", "size": 1916716, "sha256": "2aa2586e1590c14d0201385822bfb79d46bae364d1ff1df2cce24fedad9dc893", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\2023Q3_SE_26_Oct_2023_VF.pdf", "filename": "2023Q3_SE_26_Oct_2023_VF.pdf", "extension": ".pdf", "size": 1916716, "sha256": "2aa2586e1590c14d0201385822bfb79d46bae364d1ff1df2cce24fedad9dc893", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\extracted\\2023Q3_SE_26_Oct_2023_VF\\2023Q3_SE_26_Oct_2023_VF.txt", "text_chars": 85634, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q3\\extracted\\2023Q3_SE_26_Oct_2023_VF\\2023Q3_SE_26_Oct_2023_VF.extraction.json" } } ], "announcement_id": "1254994", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:52:26Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB presenterar finansiella resultat i delårsrapport för H1 2023 och Q2 2023 och ger en affärsuppdatering", "category": "Halvårsrapport", "date": "2023-07-13", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b004911fa503d838e3a273505e6367153&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "Q22023 SE 13 Jul 2023 VF.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2ae94d904f1f265f0a56f55900d13643", "final_url": "https://attachment.news.eu.nasdaq.com/a2ae94d904f1f265f0a56f55900d13643", "filename": "Q22023_SE_13_Jul_2023_VF.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\Q22023_SE_13_Jul_2023_VF.pdf", "content_type": "application/pdf", "size": 1874477, "sha256": "8b7b30cbb8cee4b22351ec733762410190dfa2e08bf7e87aacc76d96a4487fb2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\Q22023_SE_13_Jul_2023_VF.pdf", "filename": "Q22023_SE_13_Jul_2023_VF.pdf", "extension": ".pdf", "size": 1874477, "sha256": "8b7b30cbb8cee4b22351ec733762410190dfa2e08bf7e87aacc76d96a4487fb2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\extracted\\Q22023_SE_13_Jul_2023_VF\\Q22023_SE_13_Jul_2023_VF.txt", "text_chars": 81119, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q2\\extracted\\Q22023_SE_13_Jul_2023_VF\\Q22023_SE_13_Jul_2023_VF.extraction.json" } } ], "announcement_id": "1238156", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:52:30Z", "company": "Alligator Bioscience AB", "title": "Alligator Bioscience AB reports financial results for Q1 2023 and provides a business update", "category": "Interim report (Q1 and Q3)", "date": "2023-04-25", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2e4b66fbc08126eb49c218ccb64bedcc&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "Q12023 EN 25 Apr 2023.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa2de2744337c59d8ae5942a44827bc5d", "final_url": "https://attachment.news.eu.nasdaq.com/aa2de2744337c59d8ae5942a44827bc5d", "filename": "Q12023_EN_25_Apr_2023.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\Q12023_EN_25_Apr_2023.pdf", "content_type": "application/pdf", "size": 1826989, "sha256": "1982e9615a90b794d2dd42d787bc82f1eea842ed773ccf4e19c7e6606e56bd50", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\Q12023_EN_25_Apr_2023.pdf", "filename": "Q12023_EN_25_Apr_2023.pdf", "extension": ".pdf", "size": 1826989, "sha256": "1982e9615a90b794d2dd42d787bc82f1eea842ed773ccf4e19c7e6606e56bd50", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\extracted\\Q12023_EN_25_Apr_2023\\Q12023_EN_25_Apr_2023.txt", "text_chars": 72407, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\alligator-bioscience\\nasdaq-reports\\reports\\2023-q1\\extracted\\Q12023_EN_25_Apr_2023\\Q12023_EN_25_Apr_2023.extraction.json" } } ], "announcement_id": "1222064", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "971c084788642759e5c79d97b67258bcb7f7130d801170c48ffe0bdbbec06b07" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "e9f4df7d1eacb28534db10698b06555bc4a74a6e890d0268cc58fe0090a623e6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ab1eefc595483f826884e0b1120169c61941cfd6f29f732f9dc64c2abe18a0ae" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a4ec970f615966cd0f651f0692ffa55b2e9bb77f6a412afe12dfa7720624a10a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 11, "new_rows": 11, "total_count": null, "from_cache": false, "body_sha256": "d9eb24b3b2f429151b841f2968d50d10941ce2b622b1f496b0a9e0104489c0b1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=411&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 411, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "2c0a21862d738f48c1ce6f58b34bc541c9d6679be26d9bcdfeec96fc00eb45c0" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 9, "new_rows": 9, "total_count": null, "from_cache": false, "body_sha256": "43842a13da9037bff70162cc592716d745a2cbea3082ba420d9271257fa12efc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=9&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 9, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b227fd681bfdae6ce68633fb45ef6c607d316d497c2c58e498345eb96cdebbe9" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2009d687b4b979159e643e9897fc9051349f1b988104222c458ba57a7ef4abfc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "f2ba236533c60830be7b9d5a2f7aa3e542b97c6739fda78232badcaf16b94529" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "1350a894b723d455df56dd4267c6410b0fbf3ff9d6daff4c45a649b678f95776" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b34d0cb024abf6e8785811011e7fd616cfa8d4936d264867eb6c730bed0e1773" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 12, "new_rows": 12, "total_count": null, "from_cache": false, "body_sha256": "04d5ac4daa581de31c68742979f2b6d6f6004c763f050e69768b643c55d24571" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=412&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 412, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "242234eda50be724bf7a3816b48199ecd5bda4280eb1b107070c4eb227fd06d9" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 9, "new_rows": 9, "total_count": null, "from_cache": false, "body_sha256": "5226402ef7f4f9c0fab642f5cc72b8a7495ca99af28698814414992f96aaff27" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Alligator+Bioscience&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=9&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 9, "pagination": "row-offset", "query_text": "Alligator Bioscience", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b227fd681bfdae6ce68633fb45ef6c607d316d497c2c58e498345eb96cdebbe9" } ], "identity": { "slug": "", "instrument_id": "TX2227504", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/atorx?id=TX2227504" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Alligator Bioscience", "retrieved_at": "2026-08-07T00:52:30Z" }